Arizona Department of Health Services   Report issue

Government Phase 2
Founded: Phoenix AZ United States

Organization Overview

First Clinical Trial
2019
NCT04062890
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Arizona Department of Health Services

Active Ingredients

Drugs in Phase 2 Trials (1)

vigabatrin (sabril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glucose Intolerance (Phase 2)

Hyperinsulinism (Phase 2)

Hypertension (Phase 2)

Insulin Resistance (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1